<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 2: Advanced Malnutrition, Cachexia, and Refeeding Syndrome | AccrediPro</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge,
.meta-tag {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

.meta-badge .icon {
 font-size: 14px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

.welcome-box p {
 margin: 0;
 font-size: 16px;
 color: #44403c;
 line-height: 1.7;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li:last-child {
 border-bottom: none;
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

ul, ol {
 margin: 20px 0;
 padding-left: 24px;
}

li {
 font-size: 16px;
 line-height: 1.7;
 color: #374151;
 margin-bottom: 10px;
}

li strong {
 color: #722F37;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-header .subtitle {
 color: rgba(255, 255, 255, 0.8);
 font-size: 14px;
 margin: 4px 0 0 0;
}

.case-study-content {
 padding: 28px;
}

.patient-profile {
 display: flex;
 align-items: center;
 gap: 16px;
 padding: 16px;
 background: #f9fafb;
 border-radius: 12px;
 margin-bottom: 20px;
}

.patient-avatar {
 width: 56px;
 height: 56px;
 background: linear-gradient(135deg, #fecaca, #fca5a5);
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 28px;
 flex-shrink: 0;
}

.patient-info h4 {
 margin: 0;
 color: #722F37;
 font-size: 16px;
 font-weight: 700;
}

.patient-info p {
 margin: 4px 0 0 0;
 font-size: 14px;
 color: #6b7280;
}

/* COMPARISON GRID */
.comparison-grid {
 display: grid;
 grid-template-columns: repeat(2, 1fr);
 gap: 20px;
 margin: 32px 0;
}

.comparison-card {
 background: white;
 padding: 28px;
 border-radius: 16px;
 border: 2px solid #e5e7eb;
 transition: transform 0.2s, box-shadow 0.2s;
}

.comparison-card:hover {
 transform: translateY(-4px);
 box-shadow: 0 12px 24px rgba(0, 0, 0, 0.1);
}

.comparison-card.conventional {
 border-top: 4px solid #ef4444;
}

.comparison-card.functional {
 border-top: 4px solid #22c55e;
}

.card-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-weight: 700;
 margin-bottom: 12px;
 display: block;
}

.conventional .card-label {
 color: #dc2626;
}

.functional .card-label {
 color: #16a34a;
}

.card-text {
 font-size: 18px;
 font-style: italic;
 line-height: 1.5;
 color: #1f2937;
 margin: 0;
}

/* CONTENT LIST */
.content-list {
 list-style: none;
 padding: 0;
 margin: 24px 0;
}

.content-list li {
 padding: 12px 0 12px 36px;
 position: relative;
 font-size: 16px;
 color: #374151;
 border-bottom: 1px solid #f3f4f6;
}

.content-list li:last-child {
 border-bottom: none;
}

.content-list li::before {
 content: '‚Üí';
 position: absolute;
 left: 0;
 color: #722F37;
 font-weight: 700;
 font-size: 18px;
}

.content-list li strong {
 color: #722F37;
}

/* PRINCIPLE CARDS */
.principles-grid {
 display: flex;
 flex-direction: column;
 gap: 16px;
 margin: 32px 0;
}

.principle-card {
 background: white;
 border: 1px solid #e5e7eb;
 border-radius: 16px;
 padding: 24px;
 display: flex;
 gap: 20px;
 align-items: flex-start;
 transition: all 0.2s;
}

.principle-card:hover {
 border-color: #722F37;
 box-shadow: 0 8px 24px rgba(114, 47, 55, 0.1);
}

.principle-number {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #722F37, #722F37);
 color: white;
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-weight: 800;
 font-size: 18px;
 flex-shrink: 0;
}

.principle-content {
 flex: 1;
}

.principle-title {
 font-size: 18px;
 font-weight: 700;
 color: #1f2937;
 margin-bottom: 8px;
}

.principle-text {
 font-size: 15px;
 color: #4b5563;
 margin: 0;
 line-height: 1.6;
}

/* SYSTEMS BOX */
.systems-box {
 background: #f8fafc;
 border-radius: 20px;
 padding: 32px;
 margin: 40px 0;
 border: 1px solid #e2e8f0;
}

.systems-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
 gap: 16px;
 margin-top: 24px;
}

.system-item {
 background: white;
 padding: 20px;
 border-radius: 12px;
 border: 1px solid #e5e7eb;
}

.system-item h4 {
 color: #722F37;
 font-size: 16px;
 margin-bottom: 8px;
}

.system-item p {
 font-size: 14px;
 color: #4b5563;
 margin: 0;
 line-height: 1.6;
}

/* NUTRIENT DENSITY BOX */
.nutrient-box {
 border-radius: 20px;
 padding: 32px;
 margin: 40px 0;
}

.nutrient-box.positive {
 background: linear-gradient(135deg, #f0fdf4, #dcfce7);
 border: 1px solid #86efac;
}

.nutrient-box.positive h3 {
 color: #166534;
 margin-top: 0;
}

.nutrient-box.negative {
 background: linear-gradient(135deg, #fef2f2, #fee2e2);
 border: 1px solid #fecaca;
}

.nutrient-box.negative h3 {
 color: #991b1b;
 margin-top: 0;
}

.nutrient-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 16px;
 margin-top: 20px;
}

.nutrient-item {
 background: white;
 padding: 20px;
 border-radius: 12px;
 border: 1px solid rgba(134, 239, 172, 0.5);
}

.nutrient-item h4 {
 color: #16a34a;
 font-size: 15px;
 margin-bottom: 8px;
}

.nutrient-item p {
 font-size: 14px;
 color: #4b5563;
 margin: 0;
 line-height: 1.5;
}

/* ALERT BOXES */
.alert-box {
 padding: 24px;
 border-radius: 16px;
 margin: 32px 0;
 border-left: 4px solid;
}

.alert-box .alert-label {
 font-weight: 700;
 text-transform: uppercase;
 font-size: 11px;
 letter-spacing: 1px;
 margin-bottom: 8px;
 display: block;
}

.alert-box p {
 margin: 0;
 font-size: 15px;
}

.alert-box.warning,
.alert-box.gold {
 background: #fffbeb;
 border-color: #f59e0b;
}

.alert-box.warning .alert-label,
.alert-box.gold .alert-label {
 color: #92400e;
}

.alert-box.success {
 background: #f0fdf4;
 border-color: #22c55e;
}

.alert-box.success .alert-label {
 color: #166534;
}

.alert-box.reflect,
.alert-box.info {
 background: #faf5ff;
 border-color: #a855f7;
}

.alert-box.reflect .alert-label,
.alert-box.info .alert-label {
 color: #7e22ce;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

.coach-tip p {
 color: #713f12;
 font-size: 15px;
 margin: 0;
 line-height: 1.7;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-icon {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #0ea5e9, #0284c7);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 22px;
 flex-shrink: 0;
}

.module-connection .connection-text {
 flex: 1;
}

.module-connection .connection-text p {
 margin: 0;
 font-size: 15px;
 color: #0c4a6e;
 line-height: 1.5;
}

.module-connection .connection-text strong {
 color: #075985;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: linear-gradient(135deg, #faf5ff, #f3e8ff);
 border: 1px solid #e9d5ff;
 border-radius: 20px;
 padding: 32px;
 margin: 48px 0;
}

.question-item {
 background: white;
 padding: 24px;
 border-radius: 12px;
 margin-bottom: 16px;
 border: 1px solid #e9d5ff;
}

.question-item:last-child {
 margin-bottom: 0;
}

.question-header {
 display: flex;
 align-items: flex-start;
 gap: 12px;
}

.question-number {
 background: #a855f7;
 color: white;
 width: 28px;
 height: 28px;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 14px;
 font-weight: 700;
 flex-shrink: 0;
}

.question-text {
 font-weight: 600;
 color: #4b5563;
 font-size: 15px;
 margin: 0;
 flex: 1;
}

.reveal-btn {
 background: white;
 border: 2px solid #d8b4fe;
 color: #7e22ce;
 padding: 10px 20px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 cursor: pointer;
 transition: all 0.2s;
 margin-top: 12px;
}

.reveal-btn:hover {
 background: #7e22ce;
 color: white;
 border-color: #7e22ce;
}

.answer-text {
 display: none;
 margin-top: 16px;
 padding-top: 16px;
 border-top: 1px solid #e9d5ff;
 color: #4b5563;
 font-size: 15px;
 line-height: 1.6;
}

.answer-text.show {
 display: block;
 animation: fadeIn 0.3s ease;
}

@keyframes fadeIn {
 from {
 opacity: 0;
 transform: translateY(-8px);
 }
 to {
 opacity: 1;
 transform: translateY(0);
 }
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: linear-gradient(135deg, #f0fdf4, #dcfce7);
 border: 1px solid #86efac;
 border-radius: 20px;
 padding: 32px;
 margin: 48px 0;
}

.takeaways-box .box-label {
 color: #166534;
}

.takeaways-box ul {
 list-style: none;
 padding: 0;
 margin: 0;
}

.takeaways-box li {
 padding: 12px 0 12px 32px;
 position: relative;
 font-size: 16px;
 color: #166534;
 border-bottom: 1px solid rgba(34, 197, 94, 0.2);
}

.takeaways-box li:last-child {
 border-bottom: none;
}

.takeaways-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #22c55e;
 font-weight: 700;
 font-size: 16px;
}

/* REFERENCES - Premium Academic Style */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
 display: flex;
 align-items: center;
 gap: 8px;
}

.references-box .box-label::before {
 content: 'üìö';
}

.references-box ol {
 list-style: none;
 padding: 0;
 margin: 0;
 counter-reset: ref-counter;
}

.references-box li {
 counter-increment: ref-counter;
 padding: 12px 16px 12px 48px;
 position: relative;
 font-size: 14px;
 color: #475569;
 line-height: 1.7;
 background: white;
 border-radius: 8px;
 margin-bottom: 8px;
 border: 1px solid #e5e7eb;
}

.references-box li:last-child {
 margin-bottom: 0;
}

.references-box li::before {
 content: counter(ref-counter);
 position: absolute;
 left: 16px;
 top: 12px;
 width: 22px;
 height: 22px;
 background: #722F37;
 color: white;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

.references-box li em {
 color: #722F37;
 font-weight: 500;
}

/* RESPONSIVE */
@media (max-width: 768px) {
 .lesson-wrapper {
 padding: 24px 16px 60px;
 }

 .module-header-card {
 padding: 32px 24px;
 border-radius: 20px;
 }

 .lesson-title {
 font-size: 28px;
 }

 .comparison-grid {
 grid-template-columns: 1fr;
 }

 .systems-grid {
 grid-template-columns: 1fr;
 }

 .nutrient-grid {
 grid-template-columns: 1fr;
 }

 .toc-list {
 grid-template-columns: 1fr;
 }

 .asi-credential-strip {
 flex-direction: column;
 text-align: center;
 }

 .module-connection {
 flex-direction: column;
 text-align: center;
 }
}

/* Data Table CSS */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* Overrides based on "MANDATORY COLOR THEME" and "MANDATORY INTERACTIVE COMPONENTS" */

/* 1. Header Card Background Override */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 100%); /* Override sample gradient */
}

/* 2. Module Label Color Override */
.module-label {
 color: #722F37; /* Override sample white */
}

/* 3. General Box Label Color Override (except for specific overrides below) */
/* This will affect .toc-label, .objectives-box .box-label, .takeaways-box .box-label, .references-box .box-label */
.toc-label,
.objectives-box .box-label,
.references-box .box-label {
 color: #722F37; /* Override sample colors */
}

/* 4. Highlight Text Color */
.highlight {
 color: #722F37; /* Add text color */
}

/* 5. Objectives Box and Case Study Border-Left */
.objectives-box {
 border-left: 5px solid #722F37; /* Add specific border-left */
 /* Adjusting existing border to prevent double border or conflict */
 border-top: 1px solid #e9d5ff;
 border-right: 1px solid #e9d5ff;
 border-bottom: 1px solid #e9d5ff;
}

.case-study {
 border-left: 5px solid #722F37; /* Add specific border-left */
 /* Adjusting existing border */
 border-top: 1px solid #e5e7eb;
 border-right: 1px solid #e5e7eb;
 border-bottom: 1px solid #e5e7eb;
}

/* 6. Check Your Understanding Box & Elements (specific mandatory styles) */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914; /* Specific color for this label */
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* 7. Key Takeaways Box (specific mandatory styles) */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B; /* Specific color for this label */
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}
/* Ensure checkmark for takeaways is white/gold if list item text is white */
.takeaways-box li::before {
 color: #B8860B; /* Gold checkmark */
}

/* Coach Tip label color override */
.coach-tip .tip-label {
 color: #722F37; /* Override sample orange to burgundy */
}

/* Objectives checkmark color override */
.objectives-box li::before {
 color: #B8860B; /* Override sample purple checkmark to gold */
}

/* References number badge background */
.references-box li::before {
 background: #B8860B; /* Override sample burgundy to gold */
 color: white;
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 28: Crisis & Complex Cases - Lesson 2 of 8</span>
 <h1 class="lesson-title">Advanced Malnutrition, Cachexia, and Refeeding Syndrome</h1>
 <div class="lesson-meta">
 <span class="meta-badge"><span class="icon">‚è±Ô∏è</span> 15 min read</span>
 <span class="meta-badge"><span class="icon">üí°</span> Critical Care Nutrition</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">AccrediPro Standards Institute</div>
 <div class="title">Certified Dog Nutrition Specialist‚Ñ¢ Verified Content</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#differentiating-syndromes"><span class="section-num">01</span>Differentiating Advanced Malnutrition Syndromes</a></li>
 <li><a href="#advanced-assessment"><span class="section-num">02</span>Advanced Nutritional Assessment</a></li>
 <li><a href="#nutrient-calculations"><span class="section-num">03</span>Precise Nutrient & Energy Calculations</a></li>
 <li><a href="#refeeding-syndrome"><span class="section-num">04</span>Refeeding Syndrome: A Critical Complication</a></li>
 <li><a href="#refeeding-protocols"><span class="section-num">05</span>Implementing Safe Refeeding Protocols</a></li>
 <li><a href="#case-study-application"><span class="section-num">06</span>Case Study: Navigating Refeeding</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">üîó</div>
 <div class="connection-text">
 <p>Building on our previous lesson, <span class="highlight">Acute Nutritional Emergencies & Stabilization</span>, we now delve deeper into the chronic and complex forms of malnutrition. While acute cases often demand immediate caloric intervention, managing <span class="highlight">cachexia</span> and preventing <span class="highlight">refeeding syndrome</span> requires a nuanced approach that prioritizes careful assessment and gradual re-introduction of nutrients. Your expertise here can be life-saving.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Welcome, Certified Dog Nutrition Specialist!</h3>
 <p>In this critical lesson, we tackle the most challenging nutritional scenarios: advanced malnutrition, cachexia, and the life-threatening <span class="highlight">Refeeding Syndrome</span>. As a CDNS, you'll encounter dogs suffering from chronic illnesses, severe weight loss, and metabolic derangements that demand precise, evidence-based nutritional strategies. This lesson will equip you with the knowledge to differentiate complex wasting conditions, conduct advanced assessments, calculate precise nutritional requirements, and implement safe refeeding protocols. Mastering these concepts will elevate your ability to support critically ill patients and collaborate effectively with veterinary teams, truly setting you apart as a premium professional.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <p class="box-label">Learning Objectives</p>
 <ul>
 <li>Differentiate between starvation, sarcopenia, and pathological cachexia in critically ill dogs, understanding their unique etiologies and nutritional implications.</li>
 <li>Master advanced assessment techniques for severe malnutrition, including body composition analysis and interpretation of key biochemical markers.</li>
 <li>Calculate precise energy and nutrient requirements for cachectic or severely debilitated patients, accounting for hypermetabolic states and individual needs.</li>
 <li>Understand the pathophysiology, identify key risk factors, and recognize the clinical signs of Refeeding Syndrome.</li>
 <li>Implement gradual and safe nutritional support protocols to mitigate Refeeding Syndrome risks and optimize patient recovery, ensuring electrolyte balance and micronutrient support.</li>
 <li>Develop confidence in collaborating with veterinary professionals to manage complex nutritional cases and monitor patient progress effectively.</li>
 </ul>
 </div>

 <!-- Opening Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üìã</div>
 <div>
 <p class="title">Opening Case Study: Shadow's Wasting Battle</p>
 <p class="subtitle">Navigating Advanced Malnutrition</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <div class="patient-avatar">üêï</div>
 <div class="patient-info">
 <h4>Shadow, 8-year-old Male Neutered German Shepherd</h4>
 <p><strong>Owner:</strong> Eleanor, 52-year-old former teacher, dedicated to holistic pet care.</p>
 <p><strong>Presenting Complaint:</strong> Progressive weight loss, muscle wasting, and lethargy over 6 months despite adequate food intake. Diagnosed with advanced stage osteosarcoma 3 months prior.</p>
 <p><strong>Initial Assessment:</strong> Body Condition Score (BCS) 2/9, Muscle Condition Score (MCS) severe generalized atrophy. Weight loss of <span class="highlight">18% of ideal body weight</span> (from 35kg to 28.7kg). Bloodwork shows mild anemia, hypoalbuminemia (2.1 g/dL, reference 2.5-4.0 g/dL), and elevated inflammatory markers (CRP 15 mg/L, reference <5 mg/L).</p>
 </div>
 </div>
 <p>Eleanor was heartbroken. "Shadow has always been so robust. Now he's just fading away. I'm feeding him quality food, but he just keeps losing weight. My vet said it's 'cancer cachexia,' but what does that really mean for his food? I feel helpless."</p>
 <p class="case-context">Shadow's case highlights the complexities of <span class="highlight">pathological cachexia</span>, a severe form of malnutrition driven by underlying disease. Unlike simple starvation, cachexia involves systemic inflammation and altered metabolism, making nutritional intervention challenging. We'll explore how to approach such cases, focusing on precise assessment and tailored strategies to support dogs like Shadow.</p>
 </div>
 </div>

 <!-- Main Content -->
 <h2 id="differentiating-syndromes">Differentiating Advanced Malnutrition Syndromes</h2>

 <p>Understanding the precise nature of a dog's malnutrition is paramount. Not all weight loss is the same, and different underlying mechanisms demand distinct nutritional strategies. We must differentiate between simple starvation, sarcopenia, and pathological cachexia.</p>

 <h3>Starvation (Simple Malnutrition)</h3>
 <p><span class="highlight">Starvation</span> refers to a state of inadequate caloric intake, where the body primarily catabolizes fat stores for energy, followed by muscle protein. This typically occurs due to lack of access to food, anorexia without underlying disease, or severe malabsorption without systemic inflammation. The body adapts by decreasing metabolic rate and conserving protein as much as possible.</p>
 <ul>
 <li><strong>Primary cause:</strong> Insufficient caloric intake.</li>
 <li><strong>Metabolic response:</strong> Decreased basal metabolic rate, increased fat utilization, protein sparing (initially).</li>
 <li><strong>Reversibility:</strong> Generally reversible with adequate nutritional support.</li>
 </ul>

 <h3>Sarcopenia</h3>
 <p><span class="highlight">Sarcopenia</span> is the age-related loss of muscle mass and strength, independent of disease or caloric restriction. It's a natural, progressive process in aging animals, exacerbated by reduced physical activity. While not primarily a malnutrition syndrome in itself, it can significantly impact quality of life and predispose to injury.</p>
 <ul>
 <li><strong>Primary cause:</strong> Aging process, reduced activity.</li>
 <li><strong>Characteristic:</strong> Loss of muscle mass and strength, often with stable body weight (fat mass may increase).</li>
 <li><strong>Nutritional focus:</strong> High-quality protein, resistance exercise, specific amino acids (e.g., leucine).</li>
 </ul>

 <h3>Pathological Cachexia</h3>
 <p><span class="highlight">Cachexia</span> is a complex metabolic syndrome associated with underlying illness (e.g., cancer, chronic kidney disease, congestive heart failure, severe sepsis). It is characterized by involuntary weight loss, primarily muscle mass, often despite adequate or even increased caloric intake. It is driven by systemic inflammation, oxidative stress, and hormonal changes that lead to increased protein catabolism and suppressed protein synthesis, overriding normal appetite and energy balance signals.</p>
 <ul>
 <li><strong>Primary cause:</strong> Chronic systemic disease, leading to inflammatory and metabolic derangements.</li>
 <li><strong>Metabolic response:</strong> Increased basal metabolic rate (hypermetabolism), severe protein catabolism, insulin resistance, systemic inflammation.</li>
 <li><strong>Reversibility:</strong> Challenging to reverse without addressing the underlying disease; nutritional support aims to mitigate progression and improve quality of life.</li>
 </ul>

 <table class="data-table">
 <thead>
 <tr>
 <th>Feature</th>
 <th>Starvation</th>
 <th>Sarcopenia</th>
 <th>Cachexia</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Primary Cause</strong></td>
 <td>Inadequate caloric intake</td>
 <td>Aging process, inactivity</td>
 <td>Underlying chronic disease (e.g., cancer, CRF)</td>
 </tr>
 <tr>
 <td><strong>Weight Loss</strong></td>
 <td>Fat and muscle loss</td>
 <td>Muscle loss (fat may be stable/increased)</td>
 <td>Predominantly muscle loss, often with fat loss</td>
 </tr>
 <tr>
 <td><strong>Metabolic State</strong></td>
 <td>Hypometabolic, protein-sparing (initially)</td>
 <td>Normal to slightly reduced BMR</td>
 <td>Hypermetabolic, severe protein catabolism</td>
 </tr>
 <tr>
 <td><strong>Inflammation</strong></td>
 <td>Absent or minimal</td>
 <td>Absent or minimal</td>
 <td>Significant systemic inflammation (elevated CRP, cytokines)</td>
 </tr>
 <tr>
 <td><strong>Appetite</strong></td>
 <td>Often increased (hunger)</td>
 <td>Normal to slightly reduced</td>
 <td>Often reduced (anorexia)</td>
 </tr>
 <tr>
 <td><strong>Reversibility</strong></td>
 <td>Good prognosis with refeeding</td>
 <td>Manageable with nutrition & exercise</td>
 <td>Difficult to reverse; requires disease management</td>
 </tr>
 </tbody>
 </table>

 <div class="coach-tip">
 <div class="tip-label">Coach's Tip</div>
 <p>As a CDNS, your role in differentiating these conditions is crucial. Imagine advising a client whose elderly dog is losing muscle. If it's pure sarcopenia, your focus might be on specific protein types and exercise. If it's early cachexia due to undiagnosed kidney disease, your intervention would be vastly different, requiring veterinary collaboration and a focus on anti-inflammatory nutrients. This diagnostic clarity is your superpower!</p>
 </div>

 <h2 id="advanced-assessment">Advanced Nutritional Assessment</h2>

 <p>For severely malnourished or cachectic patients, standard Body Condition Scoring (BCS) may not fully capture the extent of muscle loss. We need more sophisticated tools.</p>

 <h3>Beyond BCS: Body Composition Analysis</h3>
 <ul>
 <li><strong>Muscle Condition Scoring (MCS):</strong> This is a hands-on assessment of muscle mass over bony prominences (temporal bones, scapulae, lumbar vertebrae, pelvic bones). MCS is scored from normal to severe atrophy and is critical for identifying sarcopenia and cachexia, even if BCS is borderline.</li>
 <li><strong>DEXA (Dual-energy X-ray Absorptiometry):</strong> While typically a research tool, DEXA provides precise measurements of lean body mass, fat mass, and bone mineral density. If available in a specialty setting, it offers the most accurate body composition data.</li>
 <li><strong>Bioelectrical Impedance Analysis (BIA):</strong> BIA estimates body composition by measuring the body's electrical resistance. It's less accurate than DEXA but more accessible and can track changes over time.</li>
 </ul>

 <h3>Biochemical Markers</h3>
 <p>Blood tests offer vital clues to metabolic status and the severity of malnutrition.</p>
 <ul>
 <li><strong>Albumin and Prealbumin:</strong> While often used as indicators of protein status, their levels are also affected by inflammation, liver disease, and hydration. <span class="highlight">Hypoalbuminemia (<2.5 g/dL)</span> can indicate severe protein-energy malnutrition or significant inflammatory protein loss (e.g., protein-losing enteropathy). Prealbumin has a shorter half-life and may reflect more acute changes.</li>
 <li><strong>C-Reactive Protein (CRP) & Cytokines:</strong> Elevated levels indicate systemic inflammation, a hallmark of cachexia. Monitoring CRP can help track the inflammatory burden and response to therapy.</li>
 <li><strong>Electrolytes (Potassium, Phosphorus, Magnesium):</strong> Crucial for identifying pre-existing deficiencies common in malnourished animals and for monitoring the risk of Refeeding Syndrome. Hypophosphatemia is a key indicator of Refeeding Syndrome risk.</li>
 <li><strong>Blood Urea Nitrogen (BUN) & Creatinine:</strong> Assess kidney function and can indicate protein catabolism (elevated BUN in dehydration/high protein intake, low BUN in severe liver disease/malnutrition).</li>
 <li><strong>Nitrogen Balance:</strong> Calculated by comparing nitrogen intake (from protein) to nitrogen excretion (in urine/feces). A <span class="highlight">negative nitrogen balance</span> indicates net protein catabolism, a common feature of cachexia.</li>
 </ul>

 <h3>Functional Assessment</h3>
 <p>Beyond numbers, observing the dog's physical capabilities provides valuable context.</p>
 <ul>
 <li><strong>Activity Levels:</strong> Document changes in energy, play, and willingness to move.</li>
 <li><strong>Strength & Endurance:</strong> Observe ability to rise, walk, climb stairs, and sustain activity.</li>
 <li><strong>Quality of Life Scales:</strong> Owner-reported questionnaires can track perceived well-being and response to interventions.</li>
 </ul>

 <h2 id="nutrient-calculations">Precise Nutrient & Energy Calculations for Complex Patients</h2>

 <p>Calculating caloric and nutrient needs for severely debilitated or cachectic dogs requires a careful, individualized approach. The goal is to provide adequate energy to halt catabolism and promote anabolism, while avoiding the dangers of overfeeding, especially Refeeding Syndrome.</p>

 <h3>Understanding Hypermetabolic States</h3>
 <p>Unlike simple starvation where the body enters a hypometabolic state, <span class="highlight">cachexia is often associated with hypermetabolism</span>. This means the Resting Energy Requirement (RER) can be significantly elevated due to the energy demands of the underlying disease process (e.g., fighting infection, tumor growth, tissue repair). This hypermetabolic state can increase caloric needs by <span class="highlight">1.2 to 2.0 times the calculated RER</span>, depending on the severity and nature of the illness (e.g., sepsis, major trauma, burns).</p>

 <h3>Calculating Resting Energy Requirement (RER) & Illness Factors</h3>
 <p>Recall the RER formula: <span class="highlight">RER (kcal/day) = 70 * (body weight in kg)<sup>0.75</sup></span>. Alternatively, for dogs between 2-30 kg, RER ‚âà (30 * body weight in kg) + 70.</p>
 <p>For cachectic or critically ill patients, we often start with RER and apply an illness factor (IF) or disease factor (DF) to determine the Daily Energy Requirement (DER). However, in severe malnutrition, starting with a lower percentage of RER is often safer to prevent Refeeding Syndrome.</p>
 <ul>
 <li><strong>Initial Goal:</strong> For severely malnourished patients at risk of Refeeding Syndrome, begin with <span class="highlight">20-25% of calculated RER</span>, gradually increasing over 3-7 days.</li>
 <li><strong>Moderate Malnutrition/Recovery:</strong> May tolerate 50-75% of RER initially, increasing to 100-120% RER.</li>
 <li><strong>Cachexia (without refeeding risk):</strong> May require <span class="highlight">1.2-1.6 x RER</span>, or even higher (up to 2.0 x RER) in severe hypermetabolic states, as determined by the veterinary team.</li>
 </ul>
 <p>Always work closely with the attending veterinarian to determine the appropriate starting point and rate of increase, especially for patients with active inflammatory diseases or organ dysfunction.</p>

 <h3>Macronutrient Adjustments</h3>
 <ul>
 <li><strong>Protein:</strong> Essential for tissue repair and preventing further muscle loss. Cachectic patients often benefit from <span class="highlight">increased protein intake (e.g., 2.5-4.0 g/kg BW per day)</span> of highly digestible, high-quality protein. However, excessive protein can be detrimental in cases of severe kidney or liver disease.</li>
 <li><strong>Fats:</strong> Provide concentrated energy, crucial for meeting high caloric demands without excessive volume. Medium-chain triglycerides (MCTs) can be beneficial as they are easily digested and absorbed. Omega-3 fatty acids (EPA/DHA) are important for their anti-inflammatory properties, especially in cachectic states.</li>
 <li><strong>Carbohydrates:</strong> Provide readily available energy. Complex carbohydrates are preferred.</li>
 </ul>

 <h3>Micronutrient Focus</h3>
 <p>Severely malnourished dogs are often deficient in key vitamins and minerals. These deficiencies become acutely problematic during refeeding.</p>
 <ul>
 <li><strong>B Vitamins (especially Thiamine/B1):</strong> Crucial cofactors in carbohydrate metabolism. Thiamine deficiency is a major concern in Refeeding Syndrome.</li>
 <li><strong>Potassium, Phosphorus, Magnesium:</strong> These electrolytes shift dramatically during refeeding. Pre-existing deficiencies are common and must be corrected.</li>
 <li><strong>Zinc:</strong> Important for immune function, wound healing, and appetite.</li>
 <li><strong>Antioxidants (Vitamins E, C, Selenium):</strong> Help combat oxidative stress in inflammatory conditions.</li>
 </ul>

 <div class="coach-tip">
 <div class="tip-label">Coach's Tip</div>
 <p>Your meticulous attention to detail in caloric and nutrient calculations can truly save a life. One CDNS, Sarah, a former accountant, found her precision skills invaluable. She helped a client's critically ill dog recover from severe pancreatitis by calculating daily RER, adjusting for illness factors, and carefully planning macronutrient ratios, preventing Refeeding Syndrome. Her income for that complex case was over $800 for the month of intensive support!</p>
 </div>

 <h2 id="refeeding-syndrome">Refeeding Syndrome: A Critical Complication</h2>

 <p>While the urge to rapidly refeed a severely malnourished dog is strong, doing so without caution can trigger <span class="highlight">Refeeding Syndrome</span> (RFS), a potentially fatal metabolic disturbance. This syndrome occurs when nutritional support is initiated too aggressively after a period of starvation or severe malnutrition.</p>

 <h3>Pathophysiology</h3>
 <p>During starvation, the body shifts from carbohydrate to fat and protein metabolism. Insulin levels are low, and glucagon is high. Intracellular levels of electrolytes like phosphorus, potassium, and magnesium deplete as they shift out of cells to conserve extracellular concentrations.</p>
 <p>When refeeding begins, especially with carbohydrates, there's a rapid shift back to carbohydrate metabolism. This triggers a surge in <span class="highlight">insulin</span>, which drives glucose, phosphorus, potassium, and magnesium back into cells. This rapid intracellular shift leads to profound <span class="highlight">extracellular hypophosphatemia, hypokalemia, and hypomagnesemia</span>, causing severe clinical signs.</p>

 <h3>Risk Factors</h3>
 <p>Dogs at highest risk for Refeeding Syndrome include those with:</p>
 <ul>
 <li>Prolonged anorexia or starvation (typically <span class="highlight">>3-5 days</span> without significant caloric intake).</li>
 <li>Significant weight loss (<span class="highlight">>15% of ideal body weight</span> in 1-2 months).</li>
 <li>Underlying conditions that predispose to malnutrition or electrolyte imbalances:
 <ul>
 <li>Chronic vomiting or diarrhea</li>
 <li>Gastrointestinal disease</li>
 <li>Pancreatitis</li>
 <li>Cancer cachexia</li>
 <li>Diabetic ketoacidosis</li>
 <li>Chronic renal or hepatic disease</li>
 <li>Severe cardiac disease</li>
 </ul>
 </li>
 <li>Pre-existing electrolyte deficiencies (e.g., from fluid loss).</li>
 </ul>

 <h3>Clinical Signs & Diagnosis</h3>
 <p>Clinical signs of RFS can develop within hours to days of initiating nutritional support. They are primarily related to the severe electrolyte imbalances:</p>
 <ul>
 <li><strong>Hypophosphatemia:</strong> Hemolysis, muscle weakness, tremors, ataxia, cardiac arrhythmias, respiratory failure, seizures. This is the most common and critical sign.</li>
 <li><strong>Hypokalemia:</strong> Muscle weakness, lethargy, cardiac arrhythmias, ileus.</li>
 <li><strong>Hypomagnesemia:</strong> Muscle weakness, tremors, ataxia, seizures, cardiac arrhythmias.</li>
 <li><strong>Thiamine Deficiency:</strong> Neurological signs (e.g., disorientation, blindness, seizures), cardiac dysfunction.</li>
 </ul>
 <p>Diagnosis is based on a high index of suspicion in at-risk patients, coupled with monitoring of serum electrolytes (especially phosphorus) during the initial refeeding period.</p>

 <div class="coach-tip">
 <div class="tip-label">Coach's Tip</div>
 <p>Refeeding Syndrome is a silent threat. Many owners, out of love, want to give their starving pet "all the food they can eat." This is where your education becomes vital. Explain gently but firmly that a slow and steady approach is the safest, like easing a car back onto the highway after a long breakdown. It's about nurturing, not just feeding.</p>
 </div>

 <h2 id="refeeding-protocols">Implementing Safe Nutritional Support & Refeeding Protocols</h2>

 <p>The cornerstone of preventing Refeeding Syndrome is a <span class="highlight">gradual and carefully monitored reintroduction of calories</span>, coupled with proactive electrolyte and vitamin supplementation.</p>

 <h3>Gradual Introduction of Calories</h3>
 <ol>
 <li><strong>Initial Caloric Intake:</strong> Start with <span class="highlight">20-25% of the calculated RER</span> for the dog's ideal body weight (or current body weight if ideal is unknown and the dog is severely underweight). This conservative approach minimizes the insulin surge.</li>
 <li><strong>Slow Progression:</strong> Increase caloric intake by approximately <span class="highlight">10-20% of RER per day</span>, or every 1-2 days, over a period of 3 to 7 days, until full RER (or illness-adjusted DER) is reached. The rate of increase depends on the patient's stability and electrolyte response.</li>
 <li><strong>Feeding Method:</strong> Oral feeding is preferred if possible. If not, consider assisted feeding via syringe, or placement of an esophageal or nasogastric feeding tube for continuous or frequent small bolus feedings.</li>
 </ol>

 <h3>Electrolyte Monitoring & Supplementation</h3>
 <p>Close monitoring and proactive supplementation of key electrolytes are crucial.</p>
 <ul>
 <li><strong>Potassium, Phosphorus, Magnesium:</strong> Measure serum levels <span class="highlight">every 12-24 hours for the first 3-5 days</span> of refeeding, then less frequently as the patient stabilizes. Supplementation should be initiated if levels are low or trending downwards, even if within reference range. Intravenous supplementation may be necessary under veterinary guidance.</li>
 <li><strong>Fluid Therapy:</strong> Continue appropriate fluid therapy to maintain hydration and support renal function, but monitor carefully to avoid fluid overload, especially in cardiac patients.</li>
 </ul>

 <h3>Thiamine Supplementation</h3>
 <p>Thiamine (Vitamin B1) is a critical cofactor in glucose metabolism. Depletion can lead to severe neurological signs. Proactive supplementation is highly recommended for all at-risk patients, typically <span class="highlight">2-5 mg/kg IV or IM once daily for 3-5 days</span> at the start of refeeding, then transitioning to oral supplementation.</p>

 <h3>Monitoring & Adjustment</h3>
 <ul>
 <li><strong>Clinical Signs:</strong> Closely monitor for any signs of weakness, tremors, disorientation, arrhythmias, or changes in mentation.</li>
 <li><strong>Body Weight:</strong> Track daily body weight. Rapid weight gain (more than 1-2% of body weight per day) can indicate fluid retention and potential overfeeding.</li>
 <li><strong>Appetite & Intake:</strong> Record actual food intake.</li>
 <li><strong>Stool Quality:</strong> Monitor for diarrhea, which can indicate intolerance or rapid refeeding.</li>
 <li><strong>Veterinary Collaboration:</strong> Maintain constant communication with the veterinary team. Your observations and nutritional expertise are invaluable for adjusting the refeeding plan.</li>
 </ul>

 <div class="coach-tip">
 <div class="tip-label">Coach's Tip</div>
 <p>This is where your professional integrity shines. Never hesitate to recommend immediate veterinary consultation if you suspect Refeeding Syndrome or other critical complications. Your role is supportive and educational, but always within the boundaries of a CDNS. Empowering your client means empowering them to seek the highest level of care for their pet.</p>
 </div>

 <h2 id="case-study-application">Case Study: Navigating Refeeding with Shadow</h2>

 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">ü©∫</div>
 <div>
 <p class="title">Case Study Application</p>
 <p class="subtitle">Shadow's Recovery from Cachexia & Refeeding Prevention</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <div class="patient-avatar">üêæ</div>
 <div class="patient-info">
 <h4>Shadow, 8-year-old Male Neutered German Shepherd</h4>
 <p><strong>Diagnosis:</strong> Osteosarcoma with severe cachexia.</p>
 <p><strong>Nutritional Plan by CDNS & Vet Team:</strong></p>
 <ul>
 <li><strong>Initial RER:</strong> 1100 kcal/day (for ideal body weight of 35kg).</li>
 <li><strong>Starting Intake:</strong> 25% RER = 275 kcal/day, split into 6 small meals via feeding tube.</li>
 <li><strong>Diet:</strong> High-quality, energy-dense, highly digestible therapeutic diet with increased protein (4.0 g/kg BW) and omega-3 fatty acids, provided in liquid form.</li>
 <li><strong>Supplementation:</strong> Proactive thiamine (2 mg/kg IM daily), potassium, phosphorus, and magnesium added to IV fluids and monitored every 12 hours.</li>
 <li><strong>Progression:</strong> Increased intake by 15% RER daily.</li>
 </ul>
 </div>
 </div>
 <p><strong>Outcome:</strong> Over the first 3 days, Shadow's electrolytes were closely monitored. His phosphorus dipped slightly (from 1.2 mmol/L to 0.9 mmol/L, reference 0.9-1.6 mmol/L) but stabilized with proactive supplementation. By day 5, he was tolerating 100% RER (1100 kcal/day) and showing improved energy. His inflammatory markers started a slow decline. Over the next month, with ongoing nutritional support and cancer management, Shadow gained <span class="highlight">1.5 kg (5.2% of his initial body weight)</span>, primarily lean muscle mass, as confirmed by MCS. Eleanor reported he was "acting like himself again," playing gently and showing more interest in his surroundings.</p>
 <p class="case-context">Shadow's case demonstrates the delicate balance in managing cachexia. Eleanor, empowered by her CDNS, actively participated in monitoring and feeding, providing vital feedback to the veterinary team. This collaborative, measured approach prevented Refeeding Syndrome and significantly improved Shadow's quality of life, allowing him to better tolerate his cancer treatment.</p>
 </div>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 <div class="question-item">
 <p class="question-text"><strong>1. Which of the following is a key differentiating factor between starvation and cachexia?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">The presence of significant systemic inflammation and hypermetabolism, even with adequate caloric intake, is characteristic of cachexia, whereas starvation is primarily driven by insufficient caloric intake and leads to a hypometabolic state.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>2. A 6-year-old dog has lost 20% of its body weight over 3 weeks due to severe IBD-induced anorexia. What is the recommended starting caloric intake for refeeding, relative to RER?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">For a dog with severe weight loss and prolonged anorexia, there is a high risk of Refeeding Syndrome. The recommended starting caloric intake is a conservative <span class="highlight">20-25% of the calculated RER</span>, gradually increasing over several days while monitoring electrolytes.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>3. What are the three primary electrolytes that shift dramatically during Refeeding Syndrome, leading to severe clinical signs?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">The three primary electrolytes are <span class="highlight">phosphorus, potassium, and magnesium</span>. These shift rapidly from the extracellular space into cells with the insulin surge, causing profound extracellular deficiencies.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>4. Why is thiamine supplementation crucial during the initial stages of refeeding a severely malnourished patient?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Thiamine (Vitamin B1) is a critical cofactor for enzymes involved in carbohydrate metabolism. During refeeding, the rapid increase in carbohydrate metabolism can quickly deplete thiamine stores, leading to severe neurological and cardiac dysfunction if not proactively supplemented.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li><strong>Distinguish Malnutrition Types:</strong> Accurately differentiate between starvation, sarcopenia, and pathological cachexia to tailor appropriate nutritional interventions. Cachexia, driven by systemic inflammation, requires a distinct approach compared to simple caloric deficit.</li>
 <li><strong>Advanced Assessment is Key:</strong> Utilize Muscle Condition Scoring (MCS), biochemical markers (albumin, CRP, electrolytes), and functional assessments to gain a comprehensive understanding of a patient's nutritional status beyond just BCS.</li>
 <li><strong>Precise Calculations are Vital:</strong> Calculate RER and apply appropriate illness factors for cachectic patients, understanding that hypermetabolism may increase caloric needs, but initial refeeding must be conservative. Focus on high-quality protein, energy-dense fats, and specific micronutrients.</li>
 <li><strong>Understand Refeeding Syndrome:</strong> Recognize the pathophysiology, risk factors, and clinical signs of Refeeding Syndrome, a potentially fatal metabolic complication of rapid refeeding in severely malnourished dogs.</li>
 <li><strong>Implement Safe Protocols:</strong> Initiate nutritional support gradually (20-25% RER), with proactive electrolyte (potassium, phosphorus, magnesium) and thiamine supplementation, alongside vigilant monitoring of clinical signs and lab values.</li>
 <li><strong>Collaborate for Success:</strong> Effective management of complex malnutrition requires close collaboration with the veterinary team, leveraging your expertise to optimize patient outcomes and prevent complications.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Michel, K. E. (2006). Refeeding syndrome. <em>Compendium on Continuing Education for the Practicing Veterinarian</em>, 28(10), 738-744.</li>
 <li>Freeman, L. M. (2012). Cachexia and Sarcopenia: New Definitions for an Old Problem. <em>Journal of Veterinary Internal Medicine</em>, 26(6), 1262-1263.</li>
 <li>Proulx, J., & Michel, K. E. (2007). Cachexia and sarcopenia: metabolic alterations and nutritional management in dogs and cats. <em>Veterinary Clinics of North America: Small Animal Practice</em>, 37(4), 693-704.</li>
 <li>Cornell, K., & Michel, K. E. (2012). Nutritional support in critically ill dogs and cats. <em>Journal of Veterinary Emergency and Critical Care</em>, 22(S1), S25-S32.</li>
 <li>Gross, K. L., & Yamka, R. M. (2008). Nutritional considerations for the critically ill patient. <em>Veterinary Clinics of North America: Small Animal Practice</em>, 38(1), 17-38.</li>
 <li>Baldwin, R. L., et al. (2012). Cachexia in companion animals: an overview. <em>Journal of Animal Physiology and Animal Nutrition</em>, 96(5), 785-792.</li>
 <li>Hand, M. S., Thatcher, C. D., Remillard, R. L., Roudebush, P., & Novotny, B. J. (2010). <em>Small Animal Clinical Nutrition</em>. 5th ed. Mark Morris Institute.</li>
 <li>Michel, K. E., et al. (2016). ACVIM Consensus Statement on the Diagnosis and Management of Canine and Feline Cachexia. <em>Journal of Veterinary Internal Medicine</em>, 30(2), 481-492.</li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });
</script>
</body>
</html>